Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 216 entries
View as:

Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)

Phase: N/A Priority: Normal
NCT ID: NCT01202786 Org: User:
Start: 05/31/10 End: 04/30/12 Due: 04/30/13

Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)

Phase: N/A Priority: Normal
NCT ID: NCT01857323 Org: User:
Start: 05/31/13 End: 09/30/13 Due: 09/30/14

A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01058863 Org: User:
Start: 02/28/10 End: 06/30/10 Due: 06/30/11

A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01285323 Org: User:
Start: 03/31/11 End: 04/30/14 Due: 04/30/15

Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine

Phase: N/A Priority: Normal
NCT ID: NCT00203099 Org: User:
Start: 12/31/04 End: 06/30/08 Due: 06/30/09

Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00203138 Org: User:
Start: 06/30/04 End: 12/31/06 Due: 12/31/07

A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy

Phase: N/A Priority: Normal
NCT ID: NCT04200352 Org: User:
Start: 02/04/20 End: 02/14/23 Due: 02/14/24

Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle

Phase: N/A Priority: Normal
NCT ID: NCT02817464 Org: User:
Start: 10/26/16 End: 12/03/18 Due: 12/03/19

A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046

Phase: N/A Priority: Normal
NCT ID: NCT03700658 Org: User:
Start: 01/15/19 End: 10/02/20 Due: 10/02/21

Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML

Phase: N/A Priority: Normal
NCT ID: NCT00462943 Org: User:
Start: 03/07/07 End: 06/27/13 Due: 06/27/14

An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils

Phase: N/A Priority: Normal
NCT ID: NCT02501629 Org: User:
Start: 09/29/15 End: 12/04/17 Due: 12/04/18

Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01311713 Org: User:
Start: 05/02/11 End: 10/16/13 Due: 10/16/14

A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives

Phase: N/A Priority: Normal
NCT ID: NCT01291004 Org: User:
Start: 01/31/11 End: 03/31/12 Due: 03/31/13

Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01903824 Org: User:
Start: 08/31/13 End: 12/31/13 Due: 12/31/14

A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement

Phase: N/A Priority: Normal
NCT ID: NCT02190721 Org: User:
Start: 05/12/15 End: 04/04/17 Due: 04/04/18

A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04447729 Org: User:
Start: 10/15/20 End: 02/10/22 Due: 02/10/23

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline

Phase: N/A Priority: Normal
NCT ID: NCT01879748 Org: User:
Start: 06/30/13 End: 11/30/13 Due: 11/30/14

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

Phase: N/A Priority: Normal
NCT ID: NCT06052267 Org: User:
Start: 08/30/23 End: 07/17/26 Due: 07/17/27

A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose

Phase: N/A Priority: Normal
NCT ID: NCT00202982 Org: User:
Start: 08/31/03 End: 09/30/05 Due: 09/30/06

A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05499130 Org: User:
Start: 08/29/22 End: 11/12/24 Due: 11/12/25

A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine

Phase: N/A Priority: Normal
NCT ID: NCT05458011 Org: User:
Start: 09/30/22 End: 06/13/24 Due: 06/13/25

A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01596621 Org: User:
Start: 08/06/12 End: 04/24/17 Due: 04/24/18

BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)

Phase: N/A Priority: Normal
NCT ID: NCT00605215 Org: User:
Start: 04/24/08 End: 06/10/11 Due: 06/10/12

Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils

Phase: N/A Priority: Normal
NCT ID: NCT02452190 Org: User:
Start: 09/28/15 End: 01/31/18 Due: 01/31/19

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03890666 Org: User:
Start: 10/26/20 End: 10/04/21 Due: 10/04/22